Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.
- CNRS
- SciLifeLab
- Academic Europe
- Curtin University
- GSI Helmholtzzentrum für Schwerionenforschung
- Hannover Medical School •
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Institute for bioengineering of Catalonia, IBEC
- International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences
- Queensland University of Technology
- The University of Iowa
- University of Bergen
- University of Warwick
- Łukasiewicz Research Network - Krakow Institute of Technology
- AITHYRA GmbH - Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences
- Aalborg University
- Adelaide University
- Aragon Nanoscience and Materials Institute (INMA) / CSIC-University of Zaragoza
- Delft University of Technology (TU Delft)
- Duke University
- ETH Zürich
- Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Hector Fellow Academy
- INSERM
- Institute for Ophthalmic Research
- Institute of Biochemistry and Biophysics Polish Academy of Sciences
- Institute of Neuroscience and physiology, Sahlgrenska Academy, university of Gothenburg
- Julius-Maximilians-Universität Würzburg •
- KNAW
- KU LEUVEN
- Karl Landsteiner University of Health Sciences
- Karolinska Institutet, doctoral positions
- Linköping University
- Lunds universitet
- Maastricht University (UM)
- Monash University
- Mossakowski Medical Research Institute, Polish Academy of Sciences
- Purdue University
- Technical University of Munich
- The Ohio State University
- Umeå University
- University of Amsterdam (UvA)
- University of Antwerp
- University of Cambridge
- University of Copenhagen
- University of Florida
- University of Gdansk
- University of Hamburg •
- University of Lund
- University of Mainz
- University of Oldenburg •
- University of Oslo
- University of Potsdam •
- University of Utah
- University of Warwick;
- Utrecht University
- Wageningen University & Research
- 50 more »
- « less
-
Field
-
of researchers with complementary expertise in molecular biology, oncology, medical radiation physics, radionuclide therapy, radiochemistry, magnetic resonance imaging (MRI), radiation dosimetry, and image
-
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. | Dortmund, Nordrhein Westfalen | Germany | about 8 hours ago
diagnosis, and therapy of diseases like cardiovascular diseases or cancer. Overall, the institute strives to advance precision medicine by combining knowledge from different fields such as biology, chemistry
-
19 Sep 2026 Job Information Organisation/Company CNRS Department PHysicochimie des Electrolytes et Nanosystèmes InterfaciauX Research Field Chemistry Physics » Chemical physics Physics » Biophysics
-
physics, radionuclide therapy, radiochemistry, magnetic resonance imaging (MRI), radiation dosimetry, and image analysis. We offer Lund University is a public authority, which means that employees get
-
(or equivalent) and eligibility for enrollment in a doctoral school Selection process Candidates should send a curriculum vitae, a motivation letter, academic transcripts (Master 1 and Master 2, if available), a
-
research covers a wide range of topics from radiobiology, radiation physics and space research to radiation therapy. The Particle “Therapy Physics” sub-group of the Biophysics department is dedicated
-
therapies against glioblastoma. The PhD project will be conducted within the framework of the project Glioblastoma Blood-Brain Barrier Integrated Model for T-Cell Therapies (GBBRAIN-T). This fellowship is
-
industrial research environments. Project Aims: Targeted radionuclide therapy is an emerging and highly promising approach for cancer treatment. Radioconjugates combine tumour-targeting molecules with
-
machine learning and AI methods to develop clinical decision support systems for high-flow nasal cannula therapy. The project: Concerns around the possible negative consequences of delayed escalation
-
more than 50% of breast cancer cases. Current treatment strategies involve chemotherapy, endocrine therapy and, subsequently, targeted therapies. However, treatment resistance frequently develops, while